Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | 1-Benzylpiperazine | HCID 75994 | — |
| Reactant | Sodium t-butoxide | HCID 23676156 | — |
| Reactant | 5-bromo-1-(oxan-2-yl)-1H-indazole | HCID 53433826 | — |
| Catalyst | HCID 178424406 | HCID 178424406 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | HCID 69430818 | HCID 69430818 | 55% |
Reaction Steps
To a solution of the 5-bromo-1-tetrahydro-2H-pyran-2-yl-1H-indazole (250 mg, 0.889 mmol) obtained in Reference Example 5 in toluene (12 ml) were added 1-benzylpiperazine (0.24 ml, 1.35 mmol) and sodium tert-butoxide (128 mg, 1.33 mmol) at room temperature. After deaeration, bis(tri-o-tolylphosphine)-palladium(II) dichloride (70 mg, 0.0891 mmol) was added thereto and the resulting mixture was stirred at 75° C. for three and a half hours. Then, the reaction solution was poured into water and extracted with ethyl acetate. The organic layer was washed with a saturated aqueous sodium chloride solution and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the resulting residue was purified by a silica gel column chromatography (eluent: chloroform/ethyl acetate=5/2) to obtain 5-(4-benzyl-1-piperazinyl)-1-tetrahydro-2H-pyran-2-yl-1H-indazole (183 mg, 55%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07199147B2 |
|---|
| Source dataset | uspto-grants-2007_04 |
|---|
| ORD ID | ord-323bb652347d4d1c9fc88a7634e45af0 |
|---|
| Source note | uspto-grants-2007_04 |
|---|